Member Info for Indiscipline

The share price is firming above mid 14's. We were in the mid 11's.

CF deal wise has been as good as his word. The testing has not come off as he would have liked if being brutally honest. But, that is not the main thrust of business. The trials are progressing nicely and with a great team. The genomics are also bearing fruit. Both sides of the business really picking up.

This is cash generative business now. Which will shortly have a supercharged bottom-line. That really will kick the share price up.

Swap you can sell out now. I think the price won't be hurt too much...

Deep you are entirely valid in your comments. For both of us it is perspective and timescale, which may differ.

October and November, he said were when the meat is delivered; after some nice contracts I have faith. The share price got screwed by institutions who took him and other companies for a ride.

Right now they are balancing their books and have to realise some gains, so as to advertise positive averages to new investors - it's a performance business. If you look at the year overall the stock has done well even after a raise where we got taken to the woodshed for a bit.

Timescales are personal. From the contracts, so far I have faith and believe the stock will take care of itself.
Cf has to deliver a lot more. September to October always seems to be the quiet period before Q4 and Q1 ramp up.

Mid to late October on, like you, I would expect the deals to start dropping in as promised.

November he also promised more news on Imutex. He also suggested more news on Database and wearables then.
Right now giving him a quarter seems fair after deals so far.

To be fair to CF he stated on the last presentation that the big news falls after September. The II's selling down is bloody annoying no sugar coating that crap.

In terms of challenge studies we should hear these through October and November... We have all been very patient this are the last month before things start to kick in. CF has asked for a lot of patience and we have given it him.

The raise was a bit of a disaster. It had to be done we needed the cash on the books to show stability to the big guys.
Back end of October and through November are huge for all especially CF. So far he looks confident.

The Codagenix deal points to success. Jim Simons who is one of the main backers is a multi billionaire whale ( a top maths whizz and Trading legend) who does not hand his cash over lightly. Bill Gates is not to free with his own cash. Plenty of questions with regard are trialling would have been asked and CF and Wildfire answered.

With non-covid, Imutex and Genomics I think deals will start coming on top. Can understand frustration but a couple of months will give us a much clearer picture.

Forget the life savings, forge some documents and sell their home to the National Homebuyers guys..
They can thank you later...

Well done on BZT glad it worked out. You area Colin Bird survivor few of those...

GG he's looking for 20's by October.

The bigger uplift will be Xmas and Q1 when we see it all start coming together.

Lots of cash will be generated leading to lots of opportunities for some nice easily soluble acquisitions that add to our companies. CF is a dealmaker. Small little bolt-on companies that are immediately cash accretive will start dropping in I'm sure of that making a company with a high moat and dominant in its space.

I don't think he will rush it. He knows he does not have to.
CF has a solid retail share base and will build from that.

I think he has seen that rushing things with announcements has not been the way forward. He takes his time now, as the placing pressure has dissipated and there is so much coming down the pipe in the short term. He does not need to do the rushed RNS as the share price solid and the announcements which he has planned for late September and October he is certain will move the stock into the 20's.

On IG need to plonk down 5k to buy at £1.50p

It's not all about today though.

Personally I think if we get it right our Covid work could be the absolute game changer and that is scheduled for Q1.
Stem great, but, if we are the oral tech for Covid then this is it.

If you look at the retraces each low is higher than the previous one. Shows that the support is really strong.
We have had two retraces from the 16p point.

We broke the downtrend. Usually the third hit of the resistance line is the one that breaks it.
All in all the stock is performing well as we wait for October.

Welcome back Bob.

I just hope JD actually does deliver both you and Helx deserve it. The newer posters are pi55ed at u for the simple reason of holding JD to account for claim after claim.

They didn't seem upset that JD suggested in the infamous £10 million trading agreement - that it's in the partners interest to get as close to the top figure as possible and it less than a £150k generated from it. They are just upset at Helx.

If he could pull it off this time you guys deserve it. Older shareholders got fiscally violated by JD and him redeeming himself would be great. GFIN has done well with a new CEO and that deal may turn Bids around.

The tide is lifting in this area... It is possible things do get turned around. I just want to see it for you guys. We went through the wringer with this stock.

Understand the frustrations but so far every time we have retraced we have made higher lows.
All here are ready to grin and bear it. October should be good.

That is a very well considered argument. There are a lot of positives from the raise.

And you are right that it is a matter of perspective and where you are on the spectrum. Long term we should be good.
The frustration is that with the PR push a lot of new shareholders were brought in. They have been burned and their view towards the company will be reflected by this.

What could have been long term holders, especially with a bit of hand holding have very negative views of board and stock. With a board that engage rather than go to the bunker we could get through this as a small hiccup. When you run a public company the clue is there - you have to work with the public. That is the frustration.

The IP is great. Yet, they have to concentrate in all areas of the business at vulnerable stages. Hopefully in short order we can get back on track and re-engage investors and extend their timelines to the perspective that touches further into the future.
That is work the board have to do now.

Some of those sells were buys. The buy price was under half way point so shown as sell.

I am in ORPH the raise occurred the drop happened. Link fund sold holdings regularly depressing the share price.
The Chairman all the way through the sales and the process was informing the shareholders where we were in the process.

That is what great Chairman do.. The raise was great. Board still have to communicate. It plays into shorts hands.

You may be happy how board have conducted things. But, there are a lot of shareholders who are not as they are massively underwater. Other would be long term shareholders have been stopped out. If you don't likedissatisfaction expressed by others, I suggest pick another board. Simple as that, mate.

Are we all praying hard enough right now. If we all come together who knows what can be achieved.
Certainly a damn site more than our board are doing right now.

strictly this is our refuge from TILS swings... Thankfully today's been a good day there.

But this has lower downward volatility and mahoosive upside over the next 2-3 years. For all the guys in here this is our banker stock. There is a reason so many of us are so deep, portfolio and percentage wise.

CF was as ever totally up front stating the big news starts hitting in October after full year financials. Key was we are cashflow positive and no need to raise again.

The amount of runway this company has in the future in the testing market is absolutely mind blowing. CF knows the potential size of this company and its opportunities are off the chart.

In the meantime, our labs are fully utilised bringing in over a mil a month. Bank balance at around £16 mill and growing.
Christmas looks very enticing with Imutex news, data and testing deals all coming before it and after it.

The Russian vaccine is the Russian tea...

This stock is now a Nasdaq stock, the way financial handling seems to be managed that starts entering the horizon.
Those lawyers start sending their circulars out fast.

The board need to get off their arse and communicate fast. This looks like a fiasco.